Test Price
2,600 AED✅ Home Collection Available
Next Generation Sequencing (NGS) for Episodic Ataxia – Genetic Panel in Dubai, UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity with ISO-certified NGS and full Sanger confirmation.
- Home Collection: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary post-test telephonic genetic counseling with our consultant medical geneticist.
- Insurance Support: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced genetic test screens for episodic ataxia types 1, 2, and other inherited ataxias using Next Generation Sequencing (NGS) with full Sanger validation, delivering a comprehensive mutation analysis covering all coding exons of CACNA1A, KCNA1, and related genes.
| Feature | Our Test | Closest Alternative (Sanger-Only Panel) |
|---|---|---|
| Methodology | NGS with Sanger confirmation | Sanger sequencing alone |
| Genetic Coverage | All coding exons of CACNA1A, KCNA1, and related genes | Limited to selected exons, misses deep intronic variants |
| Analytical Sensitivity | 99.9% (99% confidence) | ~95% |
| Turnaround Time | 40 working days | 30 working days |
| Post-test Support | Free genetic counselling session | Often not included |
The extended turnaround time reflects the comprehensive gene coverage and Sanger confirmation of all detected variants.
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist specializing in hereditary neurological disorders, I understand the diagnostic odyssey that episodic ataxia patients endure. This NGS panel provides a robust molecular diagnosis, but it must always be correlated with a detailed clinical history and neurological examination. Results should be reviewed with your neurologist or geneticist before any therapeutic decisions.”
— Lina Osama Zaki Quteineh, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed antiepileptic, acetazolamide, or other medications without your doctor’s advice. Abrupt cessation may trigger severe ataxic episodes or other neurological complications.
Exclusion Criteria & Emergency Red Flags
- This test is not appropriate for patients with active uninvestigated encephalopathy or acute stroke symptoms.
- Seek emergency care immediately if you develop sudden severe vertigo, double vision, slurred speech, or inability to stand—these may indicate a neurological emergency that must take priority over genetic testing.
- Do not use this test for prenatal diagnosis unless specifically counselled by your obstetrician and medical geneticist.
Patient FAQ & Clinical Guidance
1. Which symptoms suggest I need this episodic ataxia test?
This panel detects genetic causes behind recurring episodes of imbalance, vertigo, and muscle incoordination triggered by stress or movement.
2. How is the blood sample collected and handled?
A trained phlebotomist draws two lavender-top EDTA tubes (10 mL total) from a peripheral vein. The sample is immediately refrigerated and transported via temperature-controlled cold chain to our ISO-certified laboratory. VIP Mobile Phlebotomy is available daily from 8 AM to 11 PM.
3. What is the turnaround time and total cost?
Results are reported within 40 working days from sample receipt. The fixed price is AED 2,600, inclusive of genetic interpretation and counseling.
4. How will I receive my results and what support is provided?
A detailed report is delivered electronically and via hard copy. A complimentary telephonic session with our consultant medical geneticist is included to explain the findings and guide next steps.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly adheres to the UAE's Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for all genetic data handling, in conjunction with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Our facility operates under DHA License No. 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. All genetic testing processes are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Next Generation Sequencing (NGS) Episodic Ataxia Genetic Panel |
| Price (AED) | AED 2,600 |
| Turnaround Time | 40 working days |
| Sample Type / Matrix | Peripheral whole blood (two lavender-top EDTA tubes, 10 mL total) |
| Methodology Used | Next Generation Sequencing (NGS) with Sanger validation |
| ICD-10-CM Code | G11.8 |
| LOINC Code | 81331-4 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians